Interviews with 13 insurers showed that uncertainty over the future of the individual insurance market would do the most harm, even if the Affordable Care Act repeal is delayed.
The individual health insurance market, which is finally calming after a few turbulent years, could be thrown into a tailspin if the Affordable Care Act (ACA) is not replaced when it is repealed.
That’s the conclusion of a report published this week from a team at the Georgetown University Health Policy Institute. The paper was prepared for the Urban Institute and funded by the Robert Wood Johnson Foundation.
Authors Sabrina Corlette, JD; Kevin Lucia, JD, MPH: Justin Giovannelli, JD, MPP; and Dania Palanker, JD, MPP, conducted structured interviews with 13 insurers across 28 states. The group included large, for-profit payers that operate in multiple states, regional nonprofits, former Medicaid-only plans, and integrated provider-sponsored plans. Interviews took place between December 5, 2016, and January 11, 2017.
The insurers’ chief concern was uncertainty itself–they told the team that if a replacement is adopted alongside a repeal, they would adapt, and would be aided by a transition period. But a repeal without a replacement–even if there is a delay–would create upheaval that could threaten the stability of the individual market.
And that would come after the market has started to stabilize after a rocky start for the ACA, in which payers competed on price for a group of consumers for whom they had little or no data. Many of the new customers on the exchanges had not been insured for years, if ever. The sicker-than-expected population, combined with Congress’ decision to not fund risk corridors as called for in the ACA, led to large premium hikes for 2017.
Just as market analysts see calm in the individual market, the repeal of the ACA looms. “This emerging market stability is threatened by the considerable uncertainty over whether and for how long the marketplace will continue to exist if the ACA is repealed,” the authors wrote.
President Donald J. Trump has pushed for a rapid repeal of the ACA, but the details of a replacement are in doubt. The Senate has competing bills, which rely on health savings accounts and do not retain the individual mandate, although Trump has said he wants to retain bans on rejecting consumers based on preexisting conditions.
With the requirement for all Americans to be insured, however, most experts do not see how such a combination would work financially. As it is, ACA insurers struggled to get young, healthy consumers to enroll, despite financial penalties.
The authors asked insurers how they would respond to 3 different scenarios: 1) a repeal with no replacement; 2) a repeal with no immediate replacement, but a delayed effective date; and 3) a repeal with an immediate replacement. The payers said:
“The insurers we interviewed indicated almost unanimously that failing to provide (cost-sharing reduction) reimbursement would be financially devastating,” with 1 insurer saying this step would “undermine the industry.”
In fact, the authors reported, fear of a “death spiral” in the individual market would drive many insurers off the marketplace, and 1 respondent said the end of cost-sharing support would leave “a lot of bad options.”
An estimated 13.8 million people are projected to enroll on the exchanges for 2017; enrollment was tracking ahead of prior years, but the Trump administration canceled the final days of the marketing and enrollment reminder campaign that HHS had already funded.
Reference
Corlette S, Lucia K, Giovannelli J, Palanker D. Uncertain future for Affordable Care Act leads insurers to rethink participation, prices. Urban Institute website. http://www.urban.org/research/publication/uncertain-future-affordable-care-act-leads-insurers-rethink-participation-prices. Published January 24, 2017. Accessed January 27, 2017.
Â
Â
Â
Â
Â
Â
Â
Â
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More